Cambridge Investment Research Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-28,463
| Closed | -$394K | – | 3167 |
|
|
2021
Q4 | $394K | Buy |
28,463
+100
| +0.4% | +$1.38K | ﹤0.01% | 2298 |
|
|
2021
Q3 | $408K | Sell |
28,363
-4,902
| -15% | -$70.5K | ﹤0.01% | 2203 |
|
|
2021
Q2 | $526K | Sell |
33,265
-15,044
| -31% | -$238K | ﹤0.01% | 2015 |
|
|
2021
Q1 | $491K | Buy |
48,309
+6,114
| +14% | +$62.1K | ﹤0.01% | 1919 |
|
|
2020
Q4 | $314K | Buy |
42,195
+6,210
| +17% | +$46.2K | ﹤0.01% | 2095 |
|
|
2020
Q3 | $124K | Sell |
35,985
-17,420
| -33% | -$60K | ﹤0.01% | 2363 |
|
|
2020
Q2 | $254K | Buy |
+53,405
| New | +$254K | ﹤0.01% | 2016 |
|